Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (TNDM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
tndm · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Tandem Diabetes Care, Inc. (TNDM) measures how much investors pay for each dollar of the company's trailing earnings. TNDM's current PE ratio of N/A is calculated by dividing its stock price of $18.47 by its TTM earnings per share of -$1.38.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2011 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Tandem Diabetes Care, Inc.You TNDM | $1.3B | N/A | — | -$1.38 |
 EyePoint Pharmaceuticals, Inc. EYPT | $960M | N/A | — | -$3.17 |
 Fortrea Holdings Inc. FTRE | $1.6B | N/A | — | -$10.81 |
 Integra LifeSciences Holdings Corporation IART | $1.3B | N/A | — | -$6.73 |
 InMode Ltd. INMD | $821M | 10.12x | — | $1.45 |
 Kodiak Sciences Inc. KOD | $1.6B | N/A | — | -$4.32 |
 Nurix Therapeutics, Inc. NRIX | $1.4B | N/A | — | -$3.05 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-3.04 | — | |
2024-12-31 FY2024 | — | $-1.47 | — | |
2023-12-31 FY2023 | — | $-3.43 | — | |
2022-12-31 FY2022 | — | $-1.47 | — | |
2021-12-31 FY2021 | 609.20x | $0.25 | — | |
2020-12-31 FY2020 | — | $-0.56 | — | |
2019-12-31 FY2019 | — | $-0.42 | — | |
2018-12-31 FY2018 | — | $-2.55 | — | |
2017-12-31 FY2017 | — | $-12.86 | — | |
2016-12-31 FY2016 | — | $-27.30 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Tandem Diabetes Care, Inc. (TNDM) measures how much investors pay for each dollar of the company's trailing earnings. TNDM's current PE ratio of N/A is calculated by dividing its stock price of $18.47 by its TTM earnings per share of -$1.38.
Frequently asked questions
TNDM pe ratio · 6 questionsTNDM's current PE ratio is N/A as of 2026-06-08, based on a stock price of $18.47 and TTM EPS of -$1.38. Data sourced from Financial Modeling Prep via TNDM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Tandem Diabetes Care, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08